Protomer Technologies
Founded in 2015 and based in Pasadena, California, Protomer is engineering next-generation responsive biotherapeutics that can sense molecular activators in the body. The company’s proprietary chemical biology-based Molecular Evolution of Peptide Sensors (MEPS) platform enables the development of therapeutic peptides and proteins with tunable activity that can be controlled using small molecules.
Private Company
Total funding raised: $105M
About
Founded in 2015 and based in Pasadena, California, Protomer is engineering next-generation responsive biotherapeutics that can sense molecular activators in the body. The company’s proprietary chemical biology-based Molecular Evolution of Peptide Sensors (MEPS) platform enables the development of therapeutic peptides and proteins with tunable activity that can be controlled using small molecules.